Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.
about
Role of Osteopontin in Liver DiseasesNew treatment options for alcoholic hepatitisInflammatory status in human hepatic cirrhosisAlcoholic Liver Disease: Role of CytokinesNew advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseasesOsteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in miceTransitional Remodeling of the Hepatic Extracellular Matrix in Alcohol-Induced Liver InjuryNon-invasive diagnosis of alcoholic liver disease.Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challengesNew drug targets for alcoholic liver disease.Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical RelevanceCCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitisOsteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation.Pathogenesis of alcoholic liver disease: role of oxidative metabolism.Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice.Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection.The biliary epithelium gives rise to liver progenitor cellsAnalysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate CellsKinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesisSystemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis.Defective Initiation of Liver Regeneration in Osteopontin-Deficient Mice after Partial Hepatectomy due to Insufficient Activation of IL-6/Stat3 PathwaySchistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni.Osteopontin in Immune-mediated Diseases.Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration.LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic HepatitisOsteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice.Alcoholic hepatitis: Translational approaches to develop targeted therapies.Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.A mouse model of alcoholic liver fibrosis-associated acute kidney injury identifies key molecular pathways.Targeting inflammation for the treatment of alcoholic liver disease.Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury.Treatment options for alcoholic and non-alcoholic fatty liver disease: A review.Reply: To PMID 25132354.Road to stemness in hepatocellular carcinoma.Preventive effects of indole-3-carbinol against alcohol-induced liver injury in mice via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms: Role of gut-liver-adipose tissue axis.Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.Alcoholic Hepatitis: Lost in Translation.
P2860
Q26738504-BD68669C-3217-45F1-B48E-E366BA621AD3Q26751402-45F8782E-218B-4411-BD9B-309D6968692EQ26778040-71C4F6DA-8C84-4966-9CE5-DD5172A482F2Q26783558-5EF8D76A-3132-47AC-88CD-38A267BE610DQ27026399-B5E384E7-EFE9-459C-BC62-290E1CB7663BQ27327172-B3EE7E62-6C51-43D6-B4BB-3FA7CF6F064FQ28071500-539E4820-1E4E-445E-9D3A-C3A543656815Q30427485-7C81C0D0-FFA5-48BD-A8F8-5B5B89654233Q33626594-A11F90DF-4EDD-43C0-A5CB-40C2643CA360Q33746508-9188FF15-993C-4E24-BFA8-0C1906A1EE6BQ33882332-E87266B4-8CC6-463C-B773-DDE3318AF62BQ33882408-35223303-5F5A-45AF-8EDC-E6E51A0CD9EFQ34255535-4382FC2A-9AD1-403E-B7FE-AE3553013742Q34750539-763C4AA8-AE97-4BB3-9B6C-39308F31553DQ34791455-57FAE4A3-533B-400C-9C8A-B16AF81A649FQ35168268-1DB7F570-4BD0-45D0-AEDE-73C7E1D6F28AQ35539601-18029A5C-5ABD-46FE-B688-3121F0416909Q35652638-5215B027-CAB3-42C6-8C60-33C59173D847Q35764964-CAD8555C-72EB-4904-90A2-59CA0ED8F46EQ35915822-287D618B-8CDD-4AA5-8EDB-95E3A423CC2BQ35995445-F48876F3-D058-44B0-A078-DCF11838E81CQ36002104-0C0039C9-37BD-42DC-803C-995B5B94A4F5Q36021605-2C66C81F-1576-41B3-958F-35DB3B7BC746Q36377677-C68FB2CB-C98C-439E-8958-A679630AB584Q36674421-8A5D5FF3-186C-4283-9B90-BCDF8C84E714Q37345576-63E3AF68-52F5-4E60-AF99-BB11A7A3598FQ37549558-A525B559-51CE-4E7E-912B-96FCC9CFE84BQ37666036-B07CAFC3-12A9-4DDE-88A7-0E4463D815A5Q38759707-5B579C15-91B7-4213-BDAC-5425C9AE312FQ39084507-0B98DABA-342E-4ACF-84B1-554F317655A3Q39376604-242895D9-5327-4C81-AF45-56CCA54117CBQ39392481-68908A0C-E6F9-4F93-95D8-D09C71EFA826Q40245731-A5206686-60BF-4B98-B65F-1A311FB64C01Q42695159-C4817D1B-00C3-48C8-A84C-4EDF8277A223Q46950878-A062D9F7-47D0-4BC1-87FB-1F6C0CB77E67Q47137381-E986C654-4ACB-424C-B981-CC4EB8DE1E92Q50054205-7AEB8ACF-F3A7-441B-91E4-5675FCE62D0CQ54192217-3A305B55-007E-4113-ACF1-65FCDCD33288Q55396741-F89AEFFC-9E5E-4A78-9B2F-7F05E5D83F07
P2860
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.
@en
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.
@nl
type
label
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.
@en
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.
@nl
prefLabel
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.
@en
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis
@en
P2093
Eric Nguyen-Khac
Francisco-Javier Laso
Hakim Houchi
Javier Michelena
José Altamirano
Juan Caballería
Juan G Abraldes
Marlene Domínguez
Oriol Morales-Ibanez
P2860
P304
P356
10.1002/HEP.26521
P407
P577
2013-08-19T00:00:00Z